BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32941953)

  • 1. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
    Sugiyama M; Kinoshita N; Ide S; Nomoto H; Nakamoto T; Saito S; Ishikane M; Kutsuna S; Hayakawa K; Hashimoto M; Suzuki M; Izumi S; Hojo M; Tsuchiya K; Gatanaga H; Takasaki J; Usami M; Kano T; Yanai H; Nishida N; Kanto T; Sugiyama H; Ohmagari N; Mizokami M
    Gene; 2021 Jan; 766():145145. PubMed ID: 32941953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.
    Yang Y; Shen C; Li J; Yuan J; Wei J; Huang F; Wang F; Li G; Li Y; Xing L; Peng L; Yang M; Cao M; Zheng H; Wu W; Zou R; Li D; Xu Z; Wang H; Zhang M; Zhang Z; Gao GF; Jiang C; Liu L; Liu Y
    J Allergy Clin Immunol; 2020 Jul; 146(1):119-127.e4. PubMed ID: 32360286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CXCL9 chemokine as a potential biomarker for assessing clinical severity in COVID-19 patients.
    Ibadullaeva N; Khikmatullaeva A; Mirzaev U; Kan N; Bobkova M; Musabaev E
    J Infect Dev Ctries; 2024 May; 18(5):672-678. PubMed ID: 38865391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
    J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-λ3 and CCL17 as predictors of disease progression in patients with mild to moderate COVID-19: A cohort study in a real-world setting.
    Sekimoto Y; Sekiya M; Nojiri S; Hayakawa E; Masui Y; Tajima M; Nishino K; Nishizaki Y; Takahashi K
    Respir Investig; 2023 Mar; 61(2):153-156. PubMed ID: 36682084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
    Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
    BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.
    Zhao Y; Qin L; Zhang P; Li K; Liang L; Sun J; Xu B; Dai Y; Li X; Zhang C; Peng Y; Feng Y; Li A; Hu Z; Xiang H; Ogg G; Ho LP; McMichael A; Jin R; Knight JC; Dong T; Zhang Y
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32501293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study.
    Vultaggio A; Vivarelli E; Virgili G; Lucenteforte E; Bartoloni A; Nozzoli C; Morettini A; Berni A; Malandrino D; Rossi O; Nencini F; Pieralli F; Peris A; Lagi F; Scocchera G; Spinicci M; Trotta M; Mazzetti M; Parronchi P; Cosmi L; Liotta F; Fontanari P; Mazzoni A; Salvati L; Maggi E; Annunziato F; Almerigogna F; Matucci A
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2575-2581.e2. PubMed ID: 32565226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
    Diorio C; Henrickson SE; Vella LA; McNerney KO; Chase J; Burudpakdee C; Lee JH; Jasen C; Balamuth F; Barrett DM; Banwell BL; Bernt KM; Blatz AM; Chiotos K; Fisher BT; Fitzgerald JC; Gerber JS; Gollomp K; Gray C; Grupp SA; Harris RM; Kilbaugh TJ; John ARO; Lambert M; Liebling EJ; Paessler ME; Petrosa W; Phillips C; Reilly AF; Romberg ND; Seif A; Sesok-Pizzini DA; Sullivan KE; Vardaro J; Behrens EM; Teachey DT; Bassiri H
    J Clin Invest; 2020 Nov; 130(11):5967-5975. PubMed ID: 32730233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in haemodialysis patients: A retrospective observational study.
    Beppu H; Fukuda T; Otsubo N; Kawanishi T; Ogawa T; Abe Y; Endo M; Hanawa T; Sugita C; Kikkawa Y; Hatakeyama S; Yamada T; Wakai S
    Nephrology (Carlton); 2023 Apr; 28(4):240-248. PubMed ID: 36806795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory phenotyping predicts clinical outcome in COVID-19.
    Burke H; Freeman A; Cellura DC; Stuart BL; Brendish NJ; Poole S; Borca F; Phan HTT; Sheard N; Williams S; Spalluto CM; Staples KJ; Clark TW; Wilkinson TMA;
    Respir Res; 2020 Sep; 21(1):245. PubMed ID: 32962703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
    Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.
    Yang AP; Li HM; Tao WQ; Yang XJ; Wang M; Yang WJ; Liu JP
    Aging (Albany NY); 2020 Jun; 12(11):10059-10069. PubMed ID: 32484453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.
    Hu J; Zhou J; Dong F; Tan J; Wang S; Li Z; Zhang X; Zhang H; Ming J; Huang T
    Medicine (Baltimore); 2020 Oct; 99(42):e22774. PubMed ID: 33080747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
    Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.